Humira

J&J Rejected in U.S. High Court Bid to Reinstate Abbott Verdict
Bloomberg
Tue, 02/21/12 - 10:36 am
JNJ
Abbott Laboratories
Humira
patents
Abbott Announces New Long-Term Data Evaluating Use of HUMIRA® (Adalimumab) for Patients with Long-Standing Moderate to Severe Rheumatoid Arthritis and for Patients with Early Moderate to Severe RA
Yahoo/PR NewsWire
Sun, 11/6/11 - 12:45 pm
Abbott Laboratories
Humira
rheumatoid arthritis
Abbott’s Freyman Says Humira Gained Market Share in Crohn’s, Psoriasis
Bloomberg
Wed, 07/20/11 - 12:50 pm
Crohn's Disease
psoriasis
Abbott Laboratories
Humira
Rheumatoid Arthritis Drugs May Help Curb Diabetes Development
Bloomberg
Tue, 06/21/11 - 09:51 pm
diabetes
rheumatoid arthritis
Remicade
Humira
Abbott Laboratories
Amgen
Enbrel
Abbott Overturning of $1.67 Billion J&J Patent Verdict to Stand
Bloomberg
Tue, 06/14/11 - 08:03 pm
Abbott Laboratories
JNJ
patents
Humira
Abbott Labs Sued Over Claims Humira Caused Fungal Infection
Bloomberg
Mon, 06/13/11 - 10:32 am
Abbott Laboratories
Humira
lawsuits
Abbott Labs Sued on Claims Humira Caused Permanent Eye Damage
Bloomberg
Tue, 05/24/11 - 10:04 am
Abbott Laboratories
Humira
Roche
lawsuits
Abbott's Lucky Number
Motley Fool
Wed, 05/11/11 - 08:18 pm
Humira
Abbott Laboratories
Remicade
ulcerative colitis
JNJ
Merck
Abbott’s Humira Meets Primary Endpoints in Phase III Study
Bloomberg
Tue, 05/10/11 - 10:12 am
Humira
Abbott Laboratories
ulcerative colitis
Remicade, Humira Tied to Risk of Cancer in Teens, FDA Affirms
Bloomberg
Thu, 04/14/11 - 06:20 pm
Remicade
Humira
cancer
FDA
TNF blockers
Abbott Laboratories
JNJ
Abbott’s Potential Billion-Dollar Problem
Motley Fool
Thu, 04/14/11 - 07:29 am
Abbott Laboratories
Humira
rheumatoid arthritis
Abbott’s Humira Undercut by Patients’ Resistance, Study Finds
Bloomberg
Tue, 04/12/11 - 10:27 am
rheumatoid arthritis
Abbott Laboratories
Humira
Abbott Wins Reversal of J&J’s $1.67 Billion Patent Victory
Bloomberg
Wed, 02/23/11 - 10:56 pm
JNJ
Humira
Abbott Laboratories
Bayer ‘Determined’ to Guard Rights After Humira Ruling
Bloomberg
Wed, 01/12/11 - 12:10 pm
Bayer
Humira
Abbott Laboratories
arthritis
Abbott Challenges $1.67 Billion Patent Loss to J&J Over Arthritis Therapy
Bloomberg
Tue, 11/2/10 - 06:12 pm
Abbott Laboratories
patents
Humira
J&A
arthritis
Study: More U.S. Doctors Prescribing Arthritis Drug for Off-Label Treatment of Ulcerative Colitis
DrugWatch
Thu, 08/26/10 - 06:38 pm
off-label
Humira
arthritis
ulcerative colitis
Abbott Laboratories
Is Abbott a Buy?
Motley Fool
Fri, 07/30/10 - 12:23 am
Abbott Laboratories
Humira
Solvay
Abbott’s Humira to Top Avastin as Best-Selling Drug
Bloomberg
Mon, 05/3/10 - 01:02 pm
Avastin
Abbott Laboratories
Humira
Roche
No Drug Can Cure the Health-Care Reform Infection
Motley Fool
Thu, 04/22/10 - 08:12 pm
Enbrel
Pfizer
healthcare reform
earnings
Neulasta
Amgen
Neupogen
Humira
Abbott Laboratories
Remicade
Merck
JNJ
Abbott Laboratories expects continued expansion of Humira ahead of 1Q earnings
Yahoo/AP
Mon, 04/19/10 - 05:53 pm
Abbott Laboratories
earnings
JNJ
Humira
Facet Biotech

Pages